How I treat cytopenias after CAR T-cell therapy
Increasing use of chimeric antigen receptor T-cell therapy (CAR-T) has unveiled diverse
toxicities warranting specific recognition and management. Cytopenias occurring after CAR …
toxicities warranting specific recognition and management. Cytopenias occurring after CAR …
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
This is the seventh special EBMT report on the indications for haematopoietic stem cell
transplantation for haematological diseases, solid tumours and immune disorders. Our aim …
transplantation for haematological diseases, solid tumours and immune disorders. Our aim …
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
JA Snowden, I Sánchez-Ortega… - Bone marrow …, 2022 - nature.com
For over two decades, the EBMT has updated recommendations on indications for
haematopoietic cell transplantation (HCT) practice based on clinical and scientific …
haematopoietic cell transplantation (HCT) practice based on clinical and scientific …
Eltrombopag added to immunosuppression in severe aplastic anemia
R Peffault de Latour, A Kulasekararaj… - … England Journal of …, 2022 - Mass Medical Soc
Background A single-group, phase 1–2 study indicated that eltrombopag improved the
efficacy of standard immunosuppressive therapy that entailed horse antithymocyte globulin …
efficacy of standard immunosuppressive therapy that entailed horse antithymocyte globulin …
Eltrombopag added to standard immunosuppression for aplastic anemia
Background Acquired aplastic anemia results from immune-mediated destruction of bone
marrow. Immunosuppressive therapies are effective, but reduced numbers of residual stem …
marrow. Immunosuppressive therapies are effective, but reduced numbers of residual stem …
[PDF][PDF] Guidelines for the diagnosis and management of adult aplastic anaemia.
SB Killick, N Bown, J Cavenagh… - British journal of …, 2016 - redbook.streamliners.co.nz
1The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth,
2Northern Genetics Service, Newcastle upon Tyne, 3St Bartholomew's Hospital, Barts …
2Northern Genetics Service, Newcastle upon Tyne, 3St Bartholomew's Hospital, Barts …
How I treat acquired aplastic anemia
A Bacigalupo - Blood, The Journal of the American Society of …, 2017 - ashpublications.org
Acquired severe aplastic anemia (SAA) is a rare hematologic disease associated with
significant morbidity and mortality. Immune destruction of hemopoietic stem cells plays an …
significant morbidity and mortality. Immune destruction of hemopoietic stem cells plays an …
[HTML][HTML] Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies
DJ Kuter - Haematologica, 2022 - ncbi.nlm.nih.gov
Chemotherapy-induced thrombocytopenia (CIT) is a common complication of the treatment
of non-hematologic malignancies. Many patient-related variables (eg, age, tumor type …
of non-hematologic malignancies. Many patient-related variables (eg, age, tumor type …
Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT
AM Risitano, S Marotta, P Ricci, L Marano… - Frontiers in …, 2019 - frontiersin.org
The treatment of paroxysmal nocturnal hemoglobinuria has been revolutionized by the
introduction of the anti-C5 agent eculizumab; however, eculizumab is not the cure for …
introduction of the anti-C5 agent eculizumab; however, eculizumab is not the cure for …
Aplastic anemia
NS Young - New England Journal of Medicine, 2018 - Mass Medical Soc
Aplastic Anemia | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH The New England Journal of …
Journal of Medicine homepage Advanced Search SEARCH The New England Journal of …